Does Caffeine Affect The Development Of The Very Immature Brain: Dose Response Relationship?
Funder
National Health and Medical Research Council
Funding Amount
$668,386.00
Summary
Premature birth is a major health problem worldwide. Preterm babies often develop apnoea of prematurity (AOP), which is commonly treated with caffeine. Trials indicate that preterm babies treated with low dose caffeine have less neurodevelopmental disabilities at 18 months. Higher doses of caffeine are often needed to reduce AOP but the risk of this is unknown. We will study the short and long-term effects of increasing doses of caffeine on the developing brain in a long-gestation species.
Contrary to traditional belief few cases of cerebral palsy are due to problems at birth. Most have earlier origins. Sophisticated new methods have found that many developmental brain disorders e.g. autism, intellectual disability and epilepsy are associated with submicroscopic but genetically large alterations in the genetic code of these children. This novel study will seek these alterations in a large group of Australian cerebral palsy families. The pilot data show novel and exciting findings.